- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Gastric or Gastroesophageal Junction Adenocarcinoma
Total 212555 results
-
Cancer Institute and Hospital, Chinese Academy...Completed
-
Carisma Therapeutics IncActive, not recruitingAdenocarcinoma | Stomach Neoplasms | Cancer | Breast Cancer | Head and Neck Cancer | Carcinoma, Hepatocellular | Colorectal Cancer | Pancreatic Cancer | Ovarian Neoplasms | Carcinoma, Ovarian Epithelial | Carcinoma, Transitional Cell | Breast Neoplasm | Prostate Cancer | Bile Duct Cancer | Bladder Cancer | Endometrial Cancer and other conditionsUnited States
-
Taiho Oncology, Inc.Active, not recruitingAdvanced or Metastatic Solid Tumor | Advanced or Metastatic Gastric or Gastroesophageal Cancer | Myeloid or Lymphoid Neoplasms (MLN)United States, Spain, Turkey, Hong Kong, Korea, Republic of, Belgium, Japan, Netherlands, France, Germany, Italy, Sweden, United Kingdom, Portugal, Singapore
-
AstraZenecaActive, not recruitingGastrointestinal Neoplasms | Esophagogastric JunctionBelgium, Denmark, Spain, United Kingdom, Canada, United States, Taiwan, Turkey, France, Germany, Korea, Republic of, Brazil, Hungary, Japan, Peru, Poland, Russian Federation, Netherlands, Chile, Argentina
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States, Puerto Rico
-
Basilea PharmaceuticaTerminatedGastric AdenocarcinomaSpain, United States, Korea, Republic of, Belgium, Russian Federation, United Kingdom, Italy, France, Turkey, Germany, Poland, Brazil, Australia, Argentina, Chile
-
Hoffmann-La RocheActive, not recruitingGastric and Gastroesophageal Junction CarcinomaChina
-
Five Prime Therapeutics, Inc.Zai Lab (Shanghai) Co., Ltd.CompletedGastric CancerUnited States, Spain, China, Italy, Korea, Republic of, Portugal, Taiwan, Japan, Turkey, France, Hungary, Thailand, Germany, Poland, Australia, Belgium, Romania, United Kingdom
-
Henan Cancer HospitalActive, not recruiting
-
BioInvent International ABActive, not recruitingHER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | HER2-positive Metastatic Breast CancerSpain, United Kingdom, Germany
-
Gulam ManjiMerck Sharp & Dohme LLCCompletedGastric Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
Bristol-Myers SquibbCompletedGastric Cancer | Esophagogastric Junction | Cancer of the StomachUnited States, Germany, Italy, Argentina, Australia, Belgium, France, Poland, Puerto Rico, Spain, Czechia, Austria, Canada, United Kingdom, Chile, Norway, Singapore
-
The Guthrie ClinicTerminatedAdenocarcinoma EsophagusUnited States
-
Hoffmann-La RocheActive, not recruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaChina
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Active, not recruitingGastric or Gastroesophageal Junction CancerChina
-
Al B. Benson, III, MDCelgene Corporation; Big Ten Cancer Research ConsortiumCompletedGastric Cancer | Gastro-Esophageal Junction AdenocarcinomaUnited States
-
University of California, IrvineTaiho Pharmaceutical Co., Ltd.CompletedGastric Adenocarcinoma | GastroEsophageal CancerUnited States
-
Lund University HospitalActive, not recruitingResectable Gastric and Gastroesophageal Junction AdenocarcinomaSweden, Norway
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingGastric Carcinoma | Gastroesophageal Junction AdenocarcinomaUnited States
-
Bavarian NordicActive, not recruitingChordoma | HER2-positive Breast Cancer | HER2-positive Gastric/Gastroesophageal Junction CancerUnited States
-
Krankenhaus NordwestGerman Research Foundation; Arbeitsgemeinschaft fur Internistische OnkologieActive, not recruiting
-
Seagen Inc.TerminatedCervical Cancer | Ovarian Cancer | Peripheral T-cell Lymphoma | Bladder Cancer | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Gastric Carcinoma | Classical Hodgkin Lymphoma | Diffuse Large B-cell Lymphoma | Cutaneous Melanoma | Gastroesophageal Junction...United States, Spain, Canada, United Kingdom, France, Italy
-
Roswell Park Cancer InstituteNational Comprehensive Cancer NetworkActive, not recruitingClinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8 | Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8 | Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8 | Pathologic Stage III Esophageal Adenocarcinoma AJCC v8 and other conditionsUnited States
-
European Organisation for Research and Treatment...Active, not recruitingGastric and Esophagogastric Junction AdenocarcinomaUnited Kingdom, Italy, France, Spain, Germany, Czechia, Israel, Norway, Poland
-
Seagen Inc.TerminatedUterine Cervical Neoplasms | Stomach Neoplasms | Testicular Neoplasms | Carcinoma, Non-Small-Cell Lung | Ovarian Neoplasms | Endometrial Neoplasms | Gastroesophageal Junction CarcinomaUnited States, Canada, Spain, Sweden, United Kingdom
-
Universitätsmedizin MannheimInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest; Deutsche...Active, not recruitingGastroesophageal Junction AdenocarcinomaGermany
-
Zymeworks Inc.Active, not recruitingHER2-expressing CancersUnited States, Canada, Korea, Republic of, Australia
-
QuantumLeap Healthcare CollaborativeByondis B.V.WithdrawnOvarian Cancer | Metastatic Cancer | Metastatic Breast Cancer | Bladder Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Gastroesophageal Adenocarcinoma | Ovarian Carcinoma | HER2-positive Gastric Cancer | Metastatic Gastrointestinal Carcinoid Tumor | HER2-positive Metastatic Breast... and other conditionsUnited States
-
Sumitomo Pharma America, Inc.CompletedGastric Cancer | Gastroesophageal Junction CancerUnited States, Hungary, Spain, China, Brazil, France, Australia, Czechia, Germany, Israel, Canada, United Kingdom, Japan, Belgium, Romania, Italy, Poland, Lithuania, Korea, Republic of, Bulgaria, Estonia, Russian Federation
-
Ruijin HospitalActive, not recruitingGastric and Gastroesophageal Junction (GEJ) AdenocarcinomaChina
-
University of NebraskaNational Cancer Institute (NCI)TerminatedEsophageal Adenocarcinoma | Adenocarcinoma of the Gastroesophageal Junction | Stage IIB Esophageal Cancer | Stage IIA Esophageal CancerUnited States
-
Genome & CompanyMerck KGaA, Darmstadt, GermanyActive, not recruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of
-
Fudan UniversityEnrolling by invitationGastric / Gastroesophageal Junction AdenocarcinomaChina
-
National Cancer Institute (NCI)NRG OncologyCompletedEsophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Stage IIA Esophageal Cancer AJCC v7 | Stage IIB Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IB Esophageal Cancer AJCC v7United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingEsophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 | Pathologic Stage... and other conditionsUnited States
-
Institut für Klinische Krebsforschung IKF GmbH...Active, not recruitingGastroEsophageal Cancer | Adenocarcinoma of the StomachGermany
-
National Cancer Center Hospital EastBayer Yakuhin, Ltd.Active, not recruitingGastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaJapan
-
Federation Francophone de Cancerologie DigestiveAstraZenecaActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedGastroesophageal Junction Adenocarcinoma | Stage IB Esophageal Adenocarcinoma AJCC v7 | Stage II Esophageal Adenocarcinoma AJCC v7 | Stage IIA Esophageal Adenocarcinoma AJCC v7 | Stage IIB Esophageal Adenocarcinoma AJCC v7 | Stage IIIA Esophageal Adenocarcinoma AJCC v7 | Stage IIIB Esophageal...United States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Terminated
-
AmgenTerminatedMUC17-positive Solid TumorsUnited States, Korea, Republic of, Taiwan, Spain, Austria, France, Japan, Germany, Netherlands
-
University Hospital HeidelbergGerman Cancer Research Center; University Hospital DresdenActive, not recruitingEsophageal Neoplasms | Gastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Gastric NeoplasmGermany
-
Centre Oscar LambretNational Cancer Institute, France; Ligue contre le cancer, France; Région Nord-Pas...CompletedGastric Cancer | Esophageal Cancer | Bile Duct Cancer | Pancreas Cancer | Gastroesophageal CancerFrance
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedEsophageal Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
Memorial Sloan Kettering Cancer CenterTerminatedGastric Cancer | Esophageal Cancer | Esophageal Neoplasms | Gastroesophageal Junction Cancer | Gastric Tumor | Gastroesophageal Junction Adenocarcinoma | GastroEsophageal Cancer | Esophageal Tumor | Esophagogastric Tumors | Gastroesophageal Junction TumorUnited States
-
Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo CompanyAstraZenecaCompletedNeoplasm, Breast | Adenocarcinoma, GastricTaiwan
-
Incyte Biosciences International SàrlCompletedAdvanced MalignanciesUnited States
-
MacroGenicsMerck Sharp & Dohme LLCCompletedStomach Cancer | Gastric Cancer | Esophageal CancerKorea, Republic of, United States, Taiwan, Singapore, Canada
-
Institut für Klinische Krebsforschung IKF GmbH...CompletedFLOT vs. FLOT/Ramucirumab for Perioperative Therapy of Gastric or GEJ Cancer (RAMSES) (RAMSES/FLOT7)Stomach Cancer | Gastroesophageal Junction CancerGermany, Italy
-
Elevar TherapeuticsCompletedGastric Cancer | Gastric AdenocarcinomaUnited States, United Kingdom, Korea, Republic of, France, Taiwan, Japan, Russian Federation, Germany, Italy, Poland, Romania, Ukraine